DarioHealth Corp. (DRIO) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
DRIO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
DRIO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 56.6% | -163.9% | 276.1% |
| 2024 | 49.1% | -213.6% | -158.1% |
| 2023 | 29.4% | -276.1% | -292.0% |
| 2022 | 34.9% | -205.4% | -224.9% |
| 2021 | 39.3% | -372.9% | -374.2% |
Download Data
Export DRIO earnings history in CSV or JSON format
Free sign-in required to download data
DarioHealth Corp. (DRIO) Earnings Overview
As of May 8, 2026, DarioHealth Corp. (DRIO) reported trailing twelve-month net income of $62M, reflecting +267.6% year-over-year growth. The company earned $1.24 per diluted share over the past four quarters, with a net profit margin of 276.1%.
Looking at the long-term picture, DRIO's historical earnings data spans multiple years. The company achieved its highest annual net income of $62M in fiscal 2025, representing a new all-time high.
DarioHealth Corp. maintains industry-leading profitability with a gross margin of 56.6%, operating margin of -163.9%, and net margin of 276.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including TDOC (-$171M net income, -7.9% margin), OMCL ($20M net income, 0.2% margin), NVCR (-$173M net income, -20.8% margin), DRIO has outperformed on profitability metrics. Compare DRIO vs TDOC →
DRIO Earnings vs Peers
Earnings metrics vs comparable public companies
DRIO Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $62M | +244.4% | -$37M | $1.24 | 276.1% | -163.9% |
| 2024 | -$43M | +28.1% | -$58M | $-0.74 | -158.1% | -213.6% |
| 2023 | -$59M | +4.4% | -$56M | $-1.93 | -292.0% | -276.1% |
| 2022 | -$62M | +19.0% | -$57M | $-2.63 | -224.9% | -205.4% |
| 2021 | -$77M | -160.7% | -$76M | $-4.63 | -374.2% | -372.9% |
| 2020 | -$29M | -66.0% | -$30M | $-5.55 | -388.7% | -394.7% |
| 2019 | -$18M | +0.4% | -$18M | $-7.84 | -234.6% | -234.2% |
| 2018 | -$18M | -13.1% | -$18M | $-15.21 | -240.8% | -239.2% |
| 2017 | -$16M | -44.6% | -$14M | $-32.70 | -304.5% | -278.9% |
| 2016 | -$11M | -52.4% | -$11M | $-41.85 | -388.4% | -396.0% |
See DRIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DRIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DRIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDRIO — Frequently Asked Questions
Quick answers to the most common questions about buying DRIO stock.
Is DRIO growing earnings?
DRIO EPS is $1.24, with earnings growth accelerating to +267.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $62M.
What are DRIO's profit margins?
DarioHealth Corp. net margin is +276.1%, with operating margin at -163.9%. Above-average margins indicate pricing power.
How consistent are DRIO's earnings?
DRIO earnings data spans 2012-2025. The accelerating earnings trend is +267.6% YoY. Historical data enables comparison across business cycles.